MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$342,414K
Cash and cash
equivalents
$60,241K
Prepaid expenses and
other current assets
$10,479K
Total property and
equipment
$36,146K
Total current assets
$413,134K
Marketable securities,
long-term
$111,379K
Operating lease
right-of-use assets, net
$18,143K
Property and equipment,
net
$14,867K
Other assets
$9,188K
Less accumulated
depreciation and...
$21,279K
Total assets
$566,711K
Total liabilities and
stockholders' equity
$566,711K
Total stockholders'
equity
$505,664K
Total liabilities
$61,047K
Accumulated deficit
-$716,304K
Additional
paid-in-capital
$1,221,235K
Total current
liabilities
$43,985K
Operating lease
liabilities, long-term...
$15,821K
Deferred revenue, net of
current portion
$745K
Derivative liability
$358K
Other liabilities
$138K
Accumulated other
comprehensive gain
$727K
Common stock, 0.0001
par value,...
$6K
Accrued and other
current liabilities
$26,874K
Accounts payable
$11,159K
Operating lease
liabilities, current portion
$5,592K
Deferred revenue
$360K
Back
Back
Balance Sheet
source: myfinsight.com
4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT)